HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sisson, J. C. Articles by Doherty, G. M. Search for Related Content PubMed PubMed Citation Articles by Sisson, J. C. Articles by Doherty, G. M.

The So-Called Stunning of Thyroid Tissue

¹ Division of Nuclear Medicine, Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan; and ² Division of Endocrine Surgery, Department of Surgery, University of Michigan Health System, Ann Arbor, Michigan

View larger version (29K): [in a new window]   FIGURE 1.  131I disappearance from thyroid tissues over time (see text for descriptions of patterns). Group A: patients 1, 2, and 5–8 in whom Rx/Dx was <0.6 at 2 d. During the first day Rx/Dx was near unity in all but patient 7; group B: patients 3 and 10 in whom Rx/Dx was >0.6 at 2 d and in whom Rx/Dx values changed modestly over time; and group C: patients 4 and 9 in whom Rx/Dx levels were >1.0 at 2 d. For each subject the diagnostic dose was 1 mCi (37 MBq); therapeutic dose is expressed on each graphic plot. In patients 1, 2, and 4–6, the first and second components of therapeutic disappearance of 131I are inscribed and designated k1 and k2, respectively.

View larger version (17K): [in a new window]   FIGURE 2.  Disappearance of therapeutic 131I from bodies of patients over time. Composites are of groups A, B, and C (Fig. 1).